Amidst confusion and uncertainty, state budget proposals aim to address $120 million shortfall as Florida’s health department presses ahead with planned cuts to ADAP
Weeks after Florida health officials announced sweeping cuts to the state’s AIDS Drug Assistance Program (ADAP), state lawmakers are now weighing budget proposals that would address what the Florida Department of Health (DOH) says is a $120 million shortfall in the program. Nonetheless, the health department has started the official process to enact its proposed changes originally slated for March 1, namely, tightening income eligibility requirements, removing Biktarvy—the most commonly prescribed HIV medication—from its formulary and restricting the availability of Descovy.
The crisis began in January. Claiming ADAP faced a $120 million shortfall, DOH announced plans to gut ADAP, which helps provide medication to people making up to 400% of the Federal Poverty Level (FPL). With the FPL set at $15,960, the current 400% cutoff puts the eligibility income limit at $63,840 for an individual. DOH wants to tighten the cutoff to 130%, or an annual income of $20,748.
DOH also said it was dropping Biktarvy from its formulary, and restricting Descovy to people with renal insufficiency.
Together, these changes could affect up to an estimated 12,000 people with HIV in the state.
On February 1, the first of two letters signed by 70 Florida healthcare professionals was sent to the state’s surgeon general, Dr. Joseph A. Lapudo, requesting:
• a meeting to discuss strategies to reverse Florida’s ADAP shortfall
• an immediate pause of the planned ADAP cuts
• an authorization for ADAP to cover a 90-day supply of clients’ current medication, to avoid treatment disruption.
A second letter was sent 10 days later, but as of mid-February, neither the surgeon general nor the deputy surgeon general had responded, according to the letter’s author, Jonathan Appelbaum, chair of the Florida Steering Committee for the American Academy of HIV Medicine (AAHIVM). “We have not heard anything about our requests for a 90-day supply of meds nor anything about pausing the changes while the rule making plays out,” Appelbaum wrote to POSITIVELY AWARE in an email.
In early February, the state responded to a lawsuit filed by the AIDS Healthcare Foundation, saying it would go through a formal rule-making process to make the cuts, a move that should, in theory, halt the March 1 effective date. As of press time, it’s unknown whether the cuts can—or will—go through, nor has DOH unveiled plans for how they will be made.
As part of the rule changing process, a public comment period is now open through March 4. To submit a comment, click here, then scroll down to the “Make Comment” button.
“The department’s action makes clear that legal processes have not been followed. Floridians will now have a say in what happens to this program and its effect on them,” Esteban Wood, AHF director of advocacy and legislative affairs, said in a statement. “It will also provide needed transparency, as the department has not shown why it needs to make these harmful changes, and show how it now has a claimed $120 million deficit. This program should be fully funded to continue the care needed by thousands across Florida.”
The biggest breakthrough in the crisis so far came last week when the Florida Senate released its proposed budget of $113 billion, which provides a funding pathway for ADAP.
The plan proposes spending $118 million from general revenue for the rest of the 2025–26 fiscal year, with the remainder rolled into 2026–27. Importantly, it closes the shortfall identified by DOH. Filling the gap would keep ADAP whole to cover premiums and restore eligibility to 400% FPL.
The funds are “contingent upon the availability of commensurate federal grant funds and/or additional drug rebate,” according to the bill.
Restoration of funding is not a done deal: The proposed budget would require funds to be held in reserve and that DOH submit requests to the Legislative Budget Commission asking for funds to be released.
And the House has its own proposed budget, which would have to be reconciled with the Senate’s, which has maintained an additional $29 million from general revenue as it has for the last several years for HIV/AIDS treatment and prevention. The House has a different proposal, drawing $34 million from general revenue and $34 million from federal trust funds. After the House and Senate versions are reconciled, the legislature will have to vote on the budget before the end of session in mid-March so that it can go to Governor Ron DeSantis.
Once passed, the new budget will need to be signed quickly to ensure that premium payments to current ADAP clients aren’t cut off, said Michael Rajner, a former consumer representative to the Florida Department of Health’s ADAP Advisory Workgroup and a Floridian living with HIV, in an email to POSITIVELY AWARE.
Independent of budget negotiations, the rule-making process is still moving forward and DOH has not stated they are holding off any cost-cutting measures, Rajner said. “So we are uncertain where we stand.”
There is one more complication to restoring benefits: DOH has already issued a notice of termination to the vendor who pays ADAP premiums, directing them to discontinue any future premium payments. It’s also unclear whether Biktarvy will still be eliminated from the ADAP formulary—or when—and whether clients will still need to switch to Tivicay and the generic version of Truvada.
“The [DOH] needs to step up to figure out how we can save all these plans… to ensure people continue to have access to medications and healthcare,” Rajner wrote.
Rajner said that a bipartisan coalition of Florida senators has been digging into these issues, giving the community significant hope. “But time is ticking and we need to resolve this crisis before people have their insurance policies terminated for nonpayment of premiums,” Rajner wrote.
Questions and confusion
Advocates say that while the latest developments represent progress in the fight to continue funding ADAP, nothing is finalized yet.
And while the Florida statute outlining the rule making process and challenges does not address whether the process would halt any upcoming changes. As of press time, the Florida DOH has not rescinded its March 1 deadline.
It’s not only the Florida legislature that was caught by surprise by the proposed ADAP cuts. Since DOH released its proposal in January, Floridians with HIV have been experiencing not just confusion, but outright panic, starting with confusingly worded letters—and sometimes no letters—from the health department, advocates say.
“The community has been sharing that clients did not receive letters,” Tammy Cuyler, founder of the consulting firm Empower HIV Health. “It could be that the client may have moved. It may be also that the client is homeless and does not have a forwarding address to receive mail, so there are barriers.” Cuyler also learned that letters were sent only in English, but not in Spanish, Haitian, Creole or any of the other languages spoken in Florida. “Another thing we find concerning is that the letters have HIV language exactly within the letter, which then discloses their status,” Cuyler added.
The DOH letter also suggested that ADAP clients would lose their health insurance entirely on March 1, which is not true. The premium insurance assistance from Ryan White ADAP will stop, but people with insurance will not have their coverage terminated. They will have to find another way to cover the payment gap quickly, however, and end their coverage if payments are unaffordable.
Cuyler, who has spoken with many providers throughout Florida, said that many have been alerting their clients to the changes. For people who are insured, doctors are writing 90-day prescriptions as a buffer, so their treatments are not interrupted on March 1. People without insurance may face some additional obstacles, Cuyler said.
“[Uninsured clients] can’t receive 90-day supply through the ADAP program at this time, only 30 days.” Cuyler has been encouraging ADAP staff to give providers a list of clients in their area who will be impacted by the formulary changes, to help them obtain new prescriptions and get on patient assistance programs. “So at least they have an idea that if they see the client before the case managers do that, they can inform them of this change.”
Cuyler added that ADAP clients should keep communicating with their case managers, if they have one—or actively seek one—to help them navigate the confusion.
An ominous trend
Danger signals first appeared last year, when the Republican-controlled U.S. Congress passed the 2025 federal budget reconciliation, the so-called “Big, Beautiful Bill,” which significantly reduced funding for Medicaid and limited access to insurance through the Affordable Care Act (ACA). This resulted in “rising health care insurance premiums nationwide,” the reason DOH gave for slashing ADAP, which may set the pattern for cuts and restrictions in other states.
In February, NASTAD, a non-partisan, non-profit association that represents public health officials who administer HIV and hepatitis programs in the U.S., released their first ADAP Watch in a dozen years, sharing data on recent changes that states have made to their ADAP programs, and other changes that might happen. Changes, while not as drastic as Florida’s, include financial eligibility reductions:
Pennsylvania: from 500% to 350% of the FPL, affecting nearly 1,600 clients
Kansas: from 400% to 250% of FPL, affecting about 230 clients
Delaware: from 500% to 350% of FPL, affecting about 176 clients
Rhode Island: from 500% to 400% of FPL, affecting about 50 clients
In addition, NASTAD found that several states are reducing funding for core medical and support services (Arkansas, Connecticut, Delaware, Kansas, Louisiana, Michigan, Pennsylvania, Rhode Island, Virginia and Wisconsin), restricting medical criteria for eligibility (Arizona), capping expenditures (Arizona, Colorado, Delaware, Nevada amd D.C.), cutting drugs from its formulary (Arizona, Florida, Louisiana, Michigan, Nevada, and Pennsylvania), and decreasing insurance premium assistance (Florida, Michigan, Montana, Oklahoma and Wisconsin). Other states are actively considering cost containment measures.
Cuyler encourages people whose coverage is, or may be, on the chopping block, to not panic or give up hope.
“There are individuals out here fighting on their behalf,” Cuyler said. “We know that they’re scared. We have spoken to senators. We’ve written letters to Congress. We are out here actively advocating on their behalf.”
The Florida Department of Health has not responded to POSITIVELY AWARE’s repeated requests for comment.
